Parallel Advisors, LLC Intellia Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 6 shares of NTLA stock, worth $90. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 39 84.62%
Holding current value
$90
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$19.72 - $27.36 $650 - $902
-33 Reduced 84.62%
6 $0
Q2 2024

Aug 08, 2024
SELL
$20.02 - $27.22 $720 - $979
-36 Reduced 48.0%
39 $0
Q1 2024

May 06, 2024
SELL
$23.82 - $32.8 $4,573 - $6,297
-192 Reduced 71.91%
75 $2,000
Q4 2023

Feb 09, 2024
SELL
$23.16 - $32.34 $509 - $711
-22 Reduced 7.61%
267 $8,000
Q3 2023

May 20, 2024
BUY
$31.62 - $45.78 $1,581 - $2,289
50 Added 20.92%
289 $9,000
Q3 2023

Nov 13, 2023
BUY
$31.62 - $45.78 $1,581 - $2,289
50 Added 20.92%
289 $9,000
Q2 2023

May 20, 2024
SELL
$34.58 - $46.03 $1,694 - $2,255
-49 Reduced 17.01%
239 $9,000
Q2 2023

Aug 04, 2023
SELL
$34.58 - $46.03 $1,694 - $2,255
-49 Reduced 17.01%
239 $9,000
Q1 2023

May 20, 2024
BUY
$33.3 - $44.82 $7,092 - $9,546
213 Added 284.0%
288 $10,000
Q1 2023

Apr 25, 2023
BUY
$33.3 - $44.82 $3,796 - $5,109
114 Added 65.52%
288 $10,000
Q4 2022

Feb 03, 2023
SELL
$33.21 - $62.69 $132 - $250
-4 Reduced 2.25%
174 $6,000
Q3 2022

Nov 10, 2022
BUY
$53.92 - $71.7 $53 - $71
1 Added 0.56%
178 $10,000
Q2 2022

Aug 01, 2022
SELL
$38.49 - $76.21 $885 - $1,752
-23 Reduced 11.5%
177 $9,000
Q1 2022

Apr 28, 2022
BUY
$58.27 - $118.99 $58 - $118
1 Added 0.5%
200 $14,000
Q4 2021

Jan 20, 2022
SELL
$100.76 - $138.36 $6,650 - $9,131
-66 Reduced 24.91%
199 $24,000
Q3 2021

Nov 02, 2021
BUY
$132.37 - $176.78 $18,664 - $24,925
141 Added 113.71%
265 $36,000
Q2 2021

Aug 06, 2021
SELL
$60.88 - $161.91 $1,582 - $4,209
-26 Reduced 17.33%
124 $20,000
Q1 2021

Apr 23, 2021
BUY
$46.59 - $83.68 $5,357 - $9,623
115 Added 328.57%
150 $12,000
Q4 2020

Feb 02, 2021
BUY
$18.83 - $63.53 $659 - $2,223
35 New
35 $2,000
Q4 2017

Feb 13, 2018
SELL
$17.39 - $31.12 $17,390 - $31,120
-1,000 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$15.16 - $25.75 $15,160 - $25,750
1,000
1,000 $20,000

Others Institutions Holding NTLA

# of Institutions
313
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.15B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email